Viatris Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · $19.19B market cap · Ranked #214 of 1,201
Scores well above the universe median on the composite. Ranks in the 82nd percentile overall.
Nothing notable on this side.
Figures come straight from the company’s filed quarterly report and feed the six-factor model (growth, quality, and value especially). This is a summary of what was reported — research, not a recommendation, and there are no analyst estimates behind it, so it isn’t a beat-or-miss call.
The latest raw values feeding the six factors.
Every rating we’ve ever assigned VTRS — append-only and hash-verified. We don’t revise or delete past calls.
0 rating changes across 37 snapshots — each with the factor shift that drove it.
The full append-only record of every call we’ve made on VTRS— the accountability history mainstream sites quietly edit and we can’t — is part of Proofstock Plus.
Unlock with Plus